These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19917593)

  • 1. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.
    Freyberg Z; Ferrando SJ; Javitch JA
    Am J Psychiatry; 2010 Apr; 167(4):388-96. PubMed ID: 19917593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways.
    George MY; Menze ET; Esmat A; Tadros MG; El-Demerdash E
    Life Sci; 2020 May; 249():117535. PubMed ID: 32151688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of glycogen synthase kinase-3beta in schizophrenia.
    Koros E; Dorner-Ciossek C
    Drug News Perspect; 2007 Sep; 20(7):437-45. PubMed ID: 17992266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
    Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
    J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
    Sutton LP; Rushlow WJ
    Neuroscience; 2011 Dec; 199():116-24. PubMed ID: 22001305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3.
    Sutton LP; Honardoust D; Mouyal J; Rajakumar N; Rushlow WJ
    J Neurochem; 2007 Jul; 102(1):153-69. PubMed ID: 17472703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia.
    Singh KK
    Clin Genet; 2013 Jun; 83(6):511-7. PubMed ID: 23379509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia as a GSK-3 dysregulation disorder.
    Lovestone S; Killick R; Di Forti M; Murray R
    Trends Neurosci; 2007 Apr; 30(4):142-9. PubMed ID: 17324475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.
    Karam CS; Ballon JS; Bivens NM; Freyberg Z; Girgis RR; Lizardi-Ortiz JE; Markx S; Lieberman JA; Javitch JA
    Trends Pharmacol Sci; 2010 Aug; 31(8):381-90. PubMed ID: 20579747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus.
    Orellana AM; Vasconcelos AR; Leite JA; de Sá Lima L; Andreotti DZ; Munhoz CD; Kawamoto EM; Scavone C
    Aging (Albany NY); 2015 Dec; 7(12):1094-111. PubMed ID: 26647069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic drug actions on gene modulation and signaling mechanisms.
    Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA
    Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
    McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM
    Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
    Zhao Z; Ksiezak-Reding H; Riggio S; Haroutunian V; Pasinetti GM
    Schizophr Res; 2006 May; 84(1):1-14. PubMed ID: 16581231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex.
    Roh MS; Seo MS; Kim Y; Kim SH; Jeon WJ; Ahn YM; Kang UG; Juhnn YS; Kim YS
    Exp Mol Med; 2007 Jun; 39(3):353-60. PubMed ID: 17603289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3.
    Sutton LP; Rushlow WJ
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):965-79. PubMed ID: 21777508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
    Urs NM; Snyder JC; Jacobsen JP; Peterson SM; Caron MG
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20732-7. PubMed ID: 23188793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol.
    Kimura M; Oda Y; Kimura H; Nangaku M; Hirose Y; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
    Pharmacol Biochem Behav; 2021 Mar; 202():173114. PubMed ID: 33485878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Akt-GSK-3 signaling cascade in the actions of dopamine.
    Beaulieu JM; Gainetdinov RR; Caron MG
    Trends Pharmacol Sci; 2007 Apr; 28(4):166-72. PubMed ID: 17349698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.
    Blasi G; Napolitano F; Ursini G; Taurisano P; Romano R; Caforio G; Fazio L; Gelao B; Di Giorgio A; Iacovelli L; Sinibaldi L; Popolizio T; Usiello A; Bertolino A
    Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1158-63. PubMed ID: 21187413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
    Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
    Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.